Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients expected in 2Q 2025 <li /> Compa ...

Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.

Starting this week, "Easy Japanese news in translation" will be published every Monday, Wednesday and Friday. Something that is believed to be seen f Full article 1 in 5 parents of children not ...

TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...

That includes a £25m profit hit in the current financial year, which will also be impacted by reduced expectations for sale ...

6,7 Nasal polyps can block nasal passages and lead to breathing problems, difficulty in sense of smell, nasal discharge, ...

AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a disorder characterised by ...

Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...

First-time voters told us about the issues that will be top of mind when they cast their ballots. What we heard was all over the map, literally — gun violence and housing affordability in their ...

Conversely, nasal polyps can sometimes worsen asthma symptoms, creating a challenging cycle of respiratory issues. Aspirin ...

Additionally, sinus infections are more likely to occur in people who have a deviated septum, nasal polyps, or a weakened immune system. Each of these can lead to inflammation or blockage in the ...

Windows 10 and Windows 11 have had their share of problems. According to the Microsoft Security Response Center (MSRC), the operating system experienced nearly 1280 security vulnerabilities in 2023.